BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30865487)

  • 1. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.
    Paner GP; Gandhi J; Choy B; Amin MB
    Arch Pathol Lab Med; 2019 May; 143(5):550-564. PubMed ID: 30865487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.
    Kryvenko ON; Epstein JI
    Arch Pathol Lab Med; 2016 Oct; 140(10):1140-52. PubMed ID: 26756649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation.
    Srigley JR; Delahunt B; Samaratunga H; Billis A; Cheng L; Clouston D; Evans A; Furusato B; Kench J; Leite K; MacLennan G; Moch H; Pan CC; Rioux-Leclercq N; Ro J; Shanks J; Shen S; Tsuzuki T; Varma M; Wheeler T; Yaxley J; Egevad L
    Pathology; 2019 Aug; 51(5):463-473. PubMed ID: 31279442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostate pathology recommendations from the Uropathology working group of the Spanish Society of Pathology].
    Sanz Ortega J; Gallel P; Hierro Martín MI; de Torres I
    Rev Esp Patol; 2019; 52(3):167-177. PubMed ID: 31213258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updates on Grading and Staging of Prostate Cancer.
    Braunhut BL; Punnen S; Kryvenko ON
    Surg Pathol Clin; 2018 Dec; 11(4):759-774. PubMed ID: 30447840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
    Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Amin MB; Bostwick DG; Humphrey PA; Jones EC; Reuter VE; Sakr W; Sesterhenn IA; Troncoso P; Wheeler TM; Epstein JI
    Hum Pathol; 2001 Jan; 32(1):74-80. PubMed ID: 11172298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution, controversies and the future of prostate cancer grading.
    Egevad L; Delahunt B; Yaxley J; Samaratunga H
    Pathol Int; 2019 Feb; 69(2):55-66. PubMed ID: 30694570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer grading in 2018: limitations, implementations, cribriform morphology, and biological markers.
    Montironi R; Cimadamore A; Cheng L; Lopez-Beltran A; Scarpelli M
    Int J Biol Markers; 2018 Nov; 33(4):331-334. PubMed ID: 29945478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
    Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
    Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gleason grading: past, present and future.
    Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
    Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.
    Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Epstein JI
    Hum Pathol; 2001 Jan; 32(1):81-8. PubMed ID: 11172299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of prostate cancer histopathology.
    Compérat E
    Curr Opin Urol; 2019 Nov; 29(6):587-592. PubMed ID: 31453865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.
    Grossfeld GD; Chang JJ; Broering JM; Li YP; Lubeck DP; Flanders SC; Carroll PR
    J Urol; 2001 Mar; 165(3):851-6. PubMed ID: 11176485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary grading for prostate cancer: implications for patient care.
    Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
    Eur Urol; 2013 May; 63(5):892-901. PubMed ID: 23092544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
    Sauter G; Clauditz T; Steurer S; Wittmer C; Büscheck F; Krech T; Lutz F; Lennartz M; Harms L; Lawrenz L; Möller-Koop C; Simon R; Jacobsen F; Wilczak W; Minner S; Tsourlakis MC; Chirico V; Weidemann S; Haese A; Steuber T; Salomon G; Matiu M; Vettorazzi E; Michl U; Budäus L; Tilki D; Thederan I; Pehrke D; Beyer B; Fraune C; Göbel C; Heinrich M; Juhnke M; Möller K; Bawahab AAA; Uhlig R; Huland H; Heinzer H; Graefen M; Schlomm T
    Eur Urol; 2018 May; 73(5):674-683. PubMed ID: 28117112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer grading: a decade after the 2005 modified system.
    Epstein JI
    Mod Pathol; 2018 Jan; 31(S1):S47-63. PubMed ID: 29297487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.